Oxyrane Contact: Jev Binns, Financial Director Greensheys, Manchester Science Park, 10 Pencroft Way, Manchester M15 6JJ T: 0161 227 8887 E: info@oxyrane.com W: www.oxyrane.com
Paper and Fibre Research Institute (PFI) Contact: Philip André Reme, Research Director Høgskoleringen 6B, 7491, TRONDHEIM Norway
M: +47 92246537 E: philip.reme@pfi.no W: www.pfi.no
Oxyrane develops enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases (LSDs) - where an inherited, deficient enzyme leads to undesired cellular waste accumulation and disease.
PFI is an independent research institute within wood fibre, pulp, paper and new biobased chemicals, materials and biofuels (biorefinery processes). PFI is a subsidiary of INNVENTIA AB, an internationally leading Swedish R&Dcorporation.
Pentagon Fine Chemicals
Pfizer
Contact: Alister Lloyd, Commercial Director Lower Road, Halebank, Widnes, Cheshire WA8 8NS T: 0151 422 3244 E: alloyd@pentagonchemicals.co.uk W: www.pentagonchemicals.co.uk
Contact: Alan Pettman, Senior Research Fellow Discovery Park, Sandwich, Kent T: 01304 644040 E: alan.pettman@pfizer.com W: www.pfizer.co.uk
Pentagon is a leading UK based chemical manufacturer of organic intermediates for use in the life science, petrochemical, and speciality chemicals markets.
Pfizer Worldwide R&D – Advancing Medicines and Vaccines
Pharmaq AS
Phytopharm PLC
Contact: Hans Vassgård Eid, Dir. Strategic Business Development Skogmo Industriområde, 7863, OVERHALLA Norway M: +47 482 48 632 E: hans.vassgard-eid@pharmaq.no W: www.pharmaq.com
Contact: Tim Sharpington, CEO Lakeview House, 2 Lakefield Court, Ermine Business Park, Huntingdon PE29 6UA T: 01480 437697 E: info@phytopharm.com W: www.phytopharm.com
Develops vaccines and health products to the global aquaculture industry.
Phytopharm plc is a development stage pharmaceutical Group developing novel treatments targeting diseases with high levels of unmet need, with the objective of developing products to key value inflection points before seeking late-stage development and/or commercial partners.
Phytoquest
Phytovation Ltd
Contact: Robert Nash, Managing Director Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB T: 01970 823200 E: robert.nash@phytoquest.co.uk W: www.phytoquest.co.uk
PhytoQuest owns science to innovate natural ingredients and compounds in the high-margin healthy-living products emerging from the convergence of food, pharmaceuticals, and cosmetics.
Contact: Andrew Beggin, CEO Units 8&9 Zone 6, Cibyn Industrial Estate, Caernarfon, Gwynedd LL55 2BD T: 01286 671666 E: andrewbeggin@phytovation.co.uk W: www.phytovation.co.uk
Phytovation is a young company, located in North West Wales, dedicated to the production of high quality plant extracts for use in the pharmaceutical and allied industries.
Piramal Healthcare Contact: Bob Holt, Research Director Biocatalysis R435, The Wilton Centre, Redcar, Cleveland TS10 4RF
T: 01642 438 122 E: robert.holt@piramal.com W: www.piramal.com
Pharmaceutical contract manufacturer specializing in the development and application of enzyme catalysis in organic synthesis.
39